Stockscreener 앱 받기
24.50
2.60%
0.62
시장 영업 전:
24.49
-0.01
-0.04%
전일 마감가:
$23.88
열려 있는:
$24.41
하루 거래량:
674.00K
Relative Volume:
1.15
시가총액:
$1.15B
수익:
$723.55M
순이익/손실:
$157.72M
주가수익비율:
8.1667
EPS:
3
순현금흐름:
$170.15M
1주 성능:
+1.28%
1개월 성능:
-11.87%
6개월 성능:
-51.71%
1년 성능:
-42.57%
1일 변동 폭
$24.19
$24.69
1주일 범위
$23.76
$24.69
52주 변동 폭
$22.64
$53.95
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
명칭
Amphastar Pharmaceuticals Inc
전화
909-980-9484
주소
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
AMPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
24.50 | 1.15B | 723.55M | 157.72M | 170.15M | 3.00 |
|
ZTS
Zoetis Inc
|
157.44 | 68.46B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.32 | 47.30B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.70 | 45.89B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.19 | 17.90B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
294.60 | 13.14B | 2.76B | 1.11B | 898.10M | 22.77 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-04 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-11-22 | 개시 | Wells Fargo | Equal Weight |
| 2024-03-05 | 개시 | JP Morgan | Overweight |
| 2023-11-17 | 개시 | BofA Securities | Neutral |
| 2023-07-25 | 재개 | Jefferies | Buy |
| 2022-10-21 | 재개 | Jefferies | Buy |
| 2022-07-29 | 개시 | CapitalOne | Overweight |
| 2022-01-07 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-01-08 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-10-05 | 업그레이드 | Northland Capital | Market Perform → Outperform |
| 2020-05-01 | 개시 | Northland Capital | Outperform |
| 2019-03-13 | 다운그레이드 | Needham | Buy → Hold |
| 2019-03-13 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2018-08-10 | 재확인 | Needham | Buy |
| 2018-03-13 | 재확인 | Needham | Buy |
| 2017-12-01 | 재확인 | Needham | Buy |
| 2017-11-09 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2017-09-27 | 재확인 | Needham | Buy |
| 2017-03-14 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2016-08-09 | 재확인 | Needham | Buy |
| 2016-05-10 | 재확인 | Needham | Buy |
| 2016-02-19 | 개시 | Wells Fargo | Outperform |
| 2015-06-19 | 재확인 | Needham | Buy |
| 2015-06-03 | 개시 | Raymond James | Strong Buy |
| 2014-07-21 | 개시 | Needham | Buy |
모두보기
Amphastar Pharmaceuticals Inc 주식(AMPH)의 최신 뉴스
Amphastar Pharmaceuticals (AMPH) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Insider Sell: Floyd Petersen Sells Shares of Amphastar Pharmaceuticals Inc (AMPH) - GuruFocus
Raymond James Financial Inc. Acquires Shares of 92,904 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Is the Options Market Predicting a Spike in Amphastar (AMPH) Stock? - MSN
Take off with Amphastar Pharmaceuticals Inc (AMPH): Get ready for trading - Sete News
Adversity is less terrifying than hope: Inovio Pharmaceuticals Inc (INO) - Sete News
Envestnet Asset Management Inc. Sells 2,463 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Amphastar Pharmaceuticals Q1 2025 Earnings: Key Financial Updates Coming May 7What to Watch - Stock Titan
Barclays PLC Buys 10,334 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Acquired by Oberweis Asset Management Inc. - MarketBeat
Learn to Evaluate (AMPH) using the Charts - news.stocktradersdaily.com
Fuller & Thaler Asset Management Inc. Sells 127,841 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Anaphylaxis Treatment Market Size in 7MM is expected to grow at - openPR.com
Generic Pharmaceuticals Stocks Q4 Teardown: Viatris (NASDAQ:VTRS) Vs The Rest - Yahoo Finance
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stock Position Boosted by Marshall Wace LLP - MarketBeat
Epoch Investment Partners Inc. Decreases Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals Announces Proposed Private Offering of $300.0 Million of Convertible Senior Notes - ACCESS Newswire
Mesirow Institutional Investment Management Inc. Has $14.12 Million Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
JPMorgan Chase & Co. Has $5.70 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Legal & General Group Plc Sells 3,871 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Acquired by LPL Financial LLC - Defense World
BofA Adjusts Price Target on Amphastar Pharmaceuticals to $31 From $36 - marketscreener.com
U.S. Naloxone Market Is Booming So Rapidly 2025-2032 -Amphastar Pharmaceuticals Inc., Emergent BioSolutions Inc - openPR.com
BofA Adjusts Price Target for Amphastar (AMPH) Amid Q1 Uncertain - GuruFocus
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by LSV Asset Management - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stake Lessened by Portolan Capital Management LLC - MarketBeat
JPMorgan Chase & Co. Sells 385,349 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Renaissance Technologies LLC Acquires 36,100 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Sets New 1-Year LowShould You Sell? - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by Alliancebernstein L.P. - Defense World
Geode Capital Management LLC Lowers Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar stock hits 52-week low at $22.73 amid market challenges By Investing.com - Investing.com South Africa
Amphastar stock hits 52-week low at $22.73 amid market challenges - Investing.com Canada
Bessemer Group Inc. Buys 11,609 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Franklin Resources Inc. Sells 1,060 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Is Amphastar Pharmaceuticals, Inc. (AMPH) the Best Pharma Stock to Buy for Long Term Growth? - Insider Monkey
2 Reasons to Like AMPH and 1 to Stay Skeptical - Yahoo Finance
Amphastar Pharmaceuticals' (AMPH) "Hold" Rating Reaffirmed at Needham & Company LLC - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Wellington Management Group LLP - Defense World
Hyaluronidase Market Growth, Trends & Insights 2024-2031 | Top - openPR.com
Federated Hermes Inc. Lowers Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals Inc (AMPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.92%
자본화:
|
볼륨(24시간):